ArticleIsrael journal of health policy research2021
Actionable lessons for the US COVID vaccine program.
Article in Israel journal of health policy research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Evaluation of Google search trends for COVID-19 vaccination administration efforts within an urban department of public health.Journal of public health research · 2026Article
- The COVID-19 pandemic posed many dilemmas for policymakers, which sometimes resulted in unprecedented decision-making.Israel journal of health policy research · 2023Article
- Article
- The mobile vaccine equity enhancement program-a model program for enhancing equity in vaccine availability based at a large health care system.Frontiers in public health · 2023Article
- A machine learning algorithm to analyse the effects of vaccination on COVID-19 mortality.Epidemiology and infection · 2022Article
- The global transmission of new coronavirus variants.Environmental research · 2022Article
- Optimal levels of vaccination to reduce COVID-19 infected individuals and deaths: A global analysis.Environmental research · 2022Article
- Safety assessment for temporary hospitals during the COVID-19 pandemic: A simulation approach.Safety science · 2022Article
- Preparedness of countries to face COVID-19 pandemic crisis: Strategic positioning and factors supporting effective strategies of prevention of pandemic threats.Environmental research · 2022Article
- Orange County, California COVID-19 Vaccine Equity Best Practices Checklist: A Community-Centered Call to Action for Equitable Vaccination Practices.Health equity · 2022Article
- Human sentiments monitoring during COVID-19 using AI-based modeling.Procedia computer science · 2022Article
- Sharing reflections and expressing appreciation upon completing a decade as co-editor of the IJHPR.Israel journal of health policy research · 2021Article
- Challenges to COVID-19 vaccine supply chain: Implications for sustainable development goals.International journal of production economics · 2021Article
- Addressing vaccine hesitancy and access barriers to achieve persistent progress in Israel's COVID-19 vaccination program.Israel journal of health policy research · 2021Article
- Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?Diagnostics (Basel, Switzerland) · 2021Article
- COVID-19 pandemic containment in the Caribbean Region: A review of case-management and public health strategies.AIMS public health · 2021Review
- The relationship between macro-socioeconomics determinants and COVID-19 vaccine distribution.AIMS public health · 2021Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
When attempting to provide lessons for other countries from the successful Israeli COVID-19 vaccine experience, it is important to distinguish between the modifiable and non-modifiable components identified in the article by Rosen, et al. Two specific modifiable components included in the Israeli program from which the US can learn are (a) a national (not individual state-based) strategy for vaccine distribution and administration and (b) a functioning public health infrastructure. As a federal government, the US maintains an often complex web of state and national authorities and responsibilities. The federal government assumed responsibility for the ordering, payment and procurement of COVID vaccine from manufacturers. In designing the subsequent steps in their COVID-19 vaccine distribution and administration plan, the Trump administration decided to rely on the states themselves to determine how best to implement guidance provided by the Centers for Disease Control and Prevention (CDC). This strategy resulted in 50 different plans and 50 different systems for the dissemination of vaccine doses, all at the level of each individual state. State health departments were neither financed, experienced nor uniformly possessed the expertise to develop and implement such plans. A national strategy for the distribution, and the workforce for the provision, of vaccine beyond the state level, similar to that which occurred in Israel, would have provided for greater efficiency and coordination across the country. The US public health infrastructure was ill-prepared and ill-staffed to take on the responsibility to deliver > 450 million doses of vaccine in an expeditious fashion, even if supply of vaccine was available. The failure to adequately invest in public health has been ubiquitous across the nation at all levels of government. Since the 2008 recession, state and local health departments have lost > 38,000 jobs and spending for state public health departments has dropped by 16% per capita and spending for local health departments has fallen by 18%. Hopefully, COVID-19 will be a wakeup call to the US with regard to the need for both a national strategy to address public health emergencies and the well-maintained infrastructure to make it happen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.